Presentation Information

[H935-2am-09]Highly efficient in vivo synthetic anticancer approach by resourcing mouse blood albumin as biocompatible artificial metalloenzyme

○Kyosuke Imai1, Kyohei Muguruma2, Akiko Nakamura2, Yuriko Kusakari2, Tsung-che Chang1, Ambara Rachmat Pradipta1, Katsunori Tanaka1,2 (1. Tokyo Institute of Technology, School of Materials and Chemical Technology, Department of Chemical Science and Engineering, 2. RIKEN Cluster for Pioneering Research, Biofunctional Synthetic Chemistry Laboratory)
PDF DownloadDownload PDF

Keywords:

Cancer therapy,Transition-metal catalyst,Artificial metalloenzyme,Albumin,In vivo synthesis